MetaCap

P3 Health Partners Inc. Class A (PIII)

NASDAQ: PIIIHealth CareMedical/Nursing ServicesUSD

1.69-0.17 (-9.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PIII stock chart

Technical analysis

Key statistics

All statistics
Market cap
$350.24M
EPS (TTM)
-$23.21
52-week range
1.52 – 16.89
Day range
1.63 – 1.84
Volume / Avg
23.18K / 30.85K
Beta
—

52-week range

$1.52$16.89

PIII stock today

On Nov 20, PIII ended the session at $1.69, shedding $0.17 (9.14%), versus the S&P 500's 3.70% decline. Shares are 90.0% below their 52-week high of $16.89, set on May 28, 2026 and 11.2% above the 52-week low of $1.52, near the bottom of the past year's range. PIII is down 51.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 70.4%.

P3 Health Partners has posted a net loss over the last twelve months (EPS of -$23.21), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About P3 Health Partners

Company profile

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Industry
Medical/Nursing Services
CEO
Dr. Aric Coffman M.D.
Headquarters
Henderson, NV
Employees
320
IPO year
2021
Website
p3hp.org

Financial highlights

Full financials

In fiscal 2024, P3 Health Partners generated $1.46 billion in revenue, down 2.8% from fiscal 2024, the first decline in the 6 years shown. P3 Health Partners reported a net loss of $147.9 million, compared with a loss of $135.8 million a year earlier. Operating margin was -18.5%.

P3 Health Partners annual revenue, net income and EPS
Fiscal yearFY 2024FY 2024FY 2023FY 2022FY 2020
Revenue$1.46B$1.50B$1.27B$1.05B$491.06M
Growth-2.76%+18.48%+20.67%+113.71%+237.54%
Net income$-147.95M$-135.85M$-57.77M$-270.13M$-31.41M
EPS (diluted)$-45.26$-54.06$-0.63$-6.50—

Analyst forecast

Forecast

Consensus (2 analysts)

buy

Avg. price target

$7.75+358.58%

  • Strong buy 0
  • Buy 1
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $4.00High $11.50

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$0.07 vs —

PIII news

All PIII news

P3 Health Partners peers

Health Care sector
PIII peer companies
CompanyPrice% ChgMarket capCompare
STLNStarling Oncology Inc.3.00-5.66%$305.97Mvs PIII
SRTAStrata Critical Medical Inc. Class A4.56-5.59%$407.30Mvs PIII
AUNAAuna SA Class A3.66-6.15%$271.05Mvs PIII
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs PIII
LFMDLifeMD Inc.1.45-9.40%$69.84Mvs PIII
NAKANakamoto Inc.3.44-15.89%$63.11Mvs PIII
EUDAEUDA Health Holdings Limited Class A15.96-7.69%$47.79Mvs PIII
AIRSAirSculpt Technologies Inc.0.5907-9.72%$43.67Mvs PIII

Indexes, lists and sector

P3 Health Partners stock FAQ

What is P3 Health Partners's stock price today?

PIII last traded at $1.69 as of Nov 20, 4:00 PM EST, down 9.14% on the day. Prices are delayed at least 15 minutes.

Does P3 Health Partners pay a dividend?

No. P3 Health Partners does not currently pay a regular cash dividend.

Who is P3 Health Partners's CEO?

Dr. Aric Coffman M.D. is the chief executive officer of P3 Health Partners Inc. Class A, which has about 320 employees.

Has PIII ever split its stock?

Yes. The most recent PIII stock split was a 1-for-50 split on Apr 14, 2025.

What is the PIII 52-week high?

The 52-week high for PIII is $16.89 and the 52-week low is $1.52. The stock is currently 90.0% below its high.

Compare PIII